- Home
- ARDC vs ABSI Comparison
ARDC vs ABSI Comparison
Compare ARDC & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARDC | ABSI |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 291.4M | 357.9M |
| IPO Year | 2011 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ARDC | ABSI |
|---|---|---|
| Price | $12.34 | $3.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $7.47 |
| AVG Volume (30 Days) | 119.4K | ★ 4.2M |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.64 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,534,000.00 |
| Revenue This Year | N/A | $631.04 |
| Revenue Next Year | N/A | $75.73 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.60 | $2.24 |
| 52 Week High | $15.03 | $5.23 |
Technical Indicators
Market Signals| Indicator | ARDC | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 54.99 | 59.09 |
| Support Level | $12.04 | $2.38 |
| Resistance Level | $13.55 | $3.27 |
| Average True Range (ATR) | 0.17 | 0.19 |
| MACD | 0.07 | 0.02 |
| Stochastic Oscillator | 94.12 | 76.52 |
Price Performance
Historical ComparisonAbout ARDC Ares Dynamic Credit Allocation Fund Inc.
Ares Dynamic Credit Allocation Fund Inc is a closed-end, diversified, management investment company. The Fund's investment objective is to seek an attractive risk adjusted level of total return, through current income and, secondarily, through capital appreciation. The Fund invests in a broad, dynamically managed portfolio of (i) senior secured loans, (ii) corporate bonds, (iii) other fixed-income instruments, and (iv) securities issued by entities commonly referred to as collateralized loan obligations and other asset-backed securities.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.